United States · FDA National Drug Code directory
Anthim
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69604-204_90524689-1977-4c22-b849-8aaa5f969adf
- Product NDC
- 69604-204
- Form
- SOLUTION
- Composition / generic term
- obiltoxaximab
- Labeler
- Elusys Therapeutics, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20160318
- Source listing expiry
- 20261231
Source-listed ingredients
- OBILTOXAXIMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (69604-204-02) / 6 mL in 1 VIAL, SINGLE-USE · 69604-204-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →